Novo Nordisk rolls out authorized insulin generics, following similar moves by Lilly, Sanofi
admin 6th September 2019 Uncategorised 0Following Eli Lilly and Sanofi, Novo Nordisk has become the last of the Big Three insulin makers to have come up with a plan to lower its insulin prices amid mounting criticism over their high costs in the U.S.
More: Novo Nordisk rolls out authorized insulin generics, following similar moves by Lilly, Sanofi
Source: fierce